Attached files
| file | filename |
|---|---|
| EX-31 - CERTIFICATION - NewGen BioPharma Corp. | newgen_ex31.htm |
| EX-10.2 - FORM OF PROMISSORY NOTE - NewGen BioPharma Corp. | newgen_ex102.htm |
| EX-3.1 - ARTICLES OF INCORPORATION - NewGen BioPharma Corp. | newgen_ex3.htm |
| 10-K - FORM 10-K - NewGen BioPharma Corp. | newgen_10k.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of NewGen BioPharma Corp. (the “Company”) on Form 10-K for the fiscal year ended October 31, 2016, as filed with the Securities and Exchange Commission (the “Report”), the undersigned certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:
|
|
(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
|
|
|
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: January 25, 2017
|
/s/ Jerwin Alfiler |
|
|
Jerwin Alfiler |
|
|
President, Secretary, Treasurer |
|
|
(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) |